The Tumor Embolization Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Tumor Embolization Devices Market?
The global size of the Tumor Embolization Devices Market has witnessed significant growth in the recent past. The market size was $1493.6 billion in 2024 and is projected to reach $1600.57 billion in 2025. This corresponds to a compound annual growth rate (CAGR) of 7.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Tumor Embolization Devices Industry?
The Tumor Embolization Devices Global Market is projected to reach a market size of $2286.1 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%.
Download Your Free Sample of the 2025 Tumor Embolization Devices Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Tumor Embolization Devices Market?
The key drivers in the tumor embolization devices market are:
• Increased focus on personalized medicine
• The use of combination therapies in treatment
• Advances in image-guided embolization procedures
• The adoption of telemedicine and remote consultations
Global Market Segmentation: Identifying Major Tumor Embolization Devices Industry Segments
The tumor embolization devices market covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Pre-order the 2025 Tumor Embolization Devices Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Tumor Embolization Devices Market?
The key trends in the tumor embolization devices market are:
• Personalized medicine is shaping the future of the tumor embolization devices market.
• The use of image-guided embolization is an emerging trend in this market.
• There is an innovation trend in embolic agents and transarterial chemoembolization (TACE).
• The trend of using embolization for palliative care is becoming more prevalent.
Who Are the Top Competitors & Leading Players in the Tumor Embolization Devices Market?
Major companies in the tumor embolization devices market are:
• Boston Scientific Corporation
• Medtronic plc
• Terumo Corporation
• Sirtex Medical Limited
• Merit Medical Systems Inc.
• Cook Medical LLC
• AngioDynamics Inc.
• Siemens Healthineers AG
• Johnson & Johnson
• Penumbra Inc.
• Teleflex Incorporated
• Meril Life Sciences Pvt. Ltd.
• Kaneka Corporation
• Imagion Biosystems Ltd.
• Guerbet
• BTI Biotechnology Institute S.L.
• BTG International
• Avinger Inc.
• Shape Memory Medical Inc.
• Delcath Systems Inc.
• Endoshape Inc.
• InSitu Technologies Inc.
• Monteris Medical Corporation
• NeuWave Medical Inc.
• Neoprobe Corporation
• OncoSec Medical Incorporated
• Helomics Corporation
• Hologic
• Surefire Medical Inc.
• Varian Medical Systems Inc.
Regional Dominance: Which Area Leads the Global Tumor Embolization Devices Market?
North America was the largest region in the tumor embolization devices market in 2023
